Location History:
- Koebenhavn V, DK (2015)
- Copenhagen, DK (2018)
Company Filing History:
Years Active: 2015-2018
Title: Inventor Profile: Rikke Bjerring Andersen
Introduction
Rikke Bjerring Andersen is an accomplished inventor based in Koebenhavn V, Denmark. With a remarkable portfolio of two patents, she stands out in the field of pharmaceutical innovation. Her work focuses on developing advanced drug delivery systems, demonstrating her commitment to improving medical outcomes.
Latest Patents
Rikke’s latest patents include a groundbreaking Drug Filled Delivery Assembly and Long-Acting Gastrin Derivatives. The Drug Delivery Assembly features a housing and a piston that are capable of axial displacement, creating a variable volume reservoir for fluid drugs. This assembly is designed with a fluid inlet and outlet, biasing means for piston movement, and a releasable retaining mechanism, facilitating the efficient expulsion of medication when needed.
Her second patent, involving Long-Acting Gastrin Derivatives, pertains to gastrin compounds that include derivatives, analogues, or fragments along with a derivatization group. This innovation aims at therapeutic applications that can enhance the efficacy of treatments in the medical field.
Career Highlights
Rikke is currently affiliated with Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care and other chronic conditions. Her role in the organization allows her to leverage her expertise in pharmaceutical development, contributing to the advancement of innovative drug delivery systems.
Collaborations
Throughout her career, Rikke has collaborated with prominent colleagues like Henrik Bengtsson and Jonas Kildegaard Pedersen. These partnerships have fostered an environment of creativity and collaboration, enhancing the depth of research and innovation in their field.
Conclusion
Rikke Bjerring Andersen continues to make significant strides in the realm of pharmaceutical inventions. Through her patents and collaborations, she exemplifies the transformative potential of innovative thinkers in developing solutions that address critical health challenges. Her work not only enhances drug delivery systems but also contributes to the broader landscape of medical advancements, promising improved therapies for patients worldwide.